Supreme Court Seeks Snapdeal’s Reply In Prescription Drug Sale Case
The case stems from the alleged sale of Schedule H medicine Suhagra-100 through Snapdeal by an allegedly unlicensed seller without requiring a doctor's prescription
The full text for this story couldn't be loaded here — read it at the verified source below.
Verified source · Inc42
Reported by Inc42. Open the original for full media and formatting.
More in Policy
All news
PolicyCan an Apple lawsuit derail OpenAI’s hardware plans?
On the latest episode of Equity, we debate whether Apple's lawsuit will cast over OpenAi's much-discussed plans to get into hardware and go public.
Read at TechCrunch
PolicyThe FBI reportedly won’t investigate ICE anymore
According to the New York Times, federal agents have been told that the FBI will no longer be investigating confrontations involving ICE agents. The DHS and DOJ denied the change in policy to The Times. The reported change in guidance follows renewed scrutiny of violence by ICE…
Read at The Verge
PolicyNew-Age Tech Stocks: Fino Payments Bank Surges 29%, Go Digit Leads Weekly Losers
As the June quarter earnings season gathered pace, investors remained largely cautious on listed new-age tech stocks this week despite…
Read at Inc42Apple’s lawsuit couldn’t come at a worse time for OpenAI
Apple filed a trade secrets lawsuit against OpenAI last Friday, and it’s not messing around. The complaint alleges a pattern of misconduct reaching all the way up to OpenAI’s chief hardware officer and claims more than 400 former Apple employees now work at the company. OpenAI’s…
Read at TechCrunch